Clinical Trial Update: Collaborative Study of 1,3 Butadiene Biomarkers

View source ↗

Summary

NIEHS-sponsored collaborative study evaluating 1,3-butadiene biomarkers for cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Cancer | Status: COMPLETED